Gilles de la tourette's syndrome in twins: Clinical and neurochemical data
Identifieur interne : 003114 ( Istex/Corpus ); précédent : 003113; suivant : 003115Gilles de la tourette's syndrome in twins: Clinical and neurochemical data
Auteurs : Goetz ; Caroline M. TannerSource :
- Movement Disorders [ 0885-3185 ] ; 1990.
English descriptors
- KwdEn :
Abstract
A pair of identical twins (probability of monozygosity by genetic marking = 99.99%) with Gilles de la Tourette's syndrome (GTS) were studied clinically and neurochemically. The two boys were distinguished within the family by dramatic differences in their behavior and tics. Twin 1 had severe motor tics, loud vocalizations, coprolalia, and school behavior problems, whereas twin 2 was only mildly affected. Neither boy had ever been treated with medication for his tic disorder. Lumbar puncture was performed on each after a night of bed rest. In spite of the marked clinical differences between the two boys, the major indices of dopamine and serotonin turnover in the cerebrospinal fluid were equivalent. Homovanillic acid levels were 65 and 60 ng/ml, respectively, and 5‐hydroxyindoleacetic acid levels were 36 and 39 ng/ml. Observation of these twins suggests that the phenotypic expression of GTS relates to more factors than inheritance. Neurochemical metabolites of dopamine and serotonin did not reflect the comparative clinical severity of GTS in these boys.
Url:
DOI: 10.1002/mds.870050216
Links to Exploration step
ISTEX:EAF0236C1FEF2A15BE90024F65B51E6977AE89BFLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gilles de la tourette's syndrome in twins: Clinical and neurochemical data</title><author><name sortKey="Goetz" sort="Goetz" uniqKey="Goetz" last="Goetz">Goetz</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Tanner, Caroline M" sort="Tanner, Caroline M" uniqKey="Tanner C" first="Caroline M." last="Tanner">Caroline M. Tanner</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:EAF0236C1FEF2A15BE90024F65B51E6977AE89BF</idno><date when="1990" year="1990">1990</date><idno type="doi">10.1002/mds.870050216</idno><idno type="url">https://api.istex.fr/document/EAF0236C1FEF2A15BE90024F65B51E6977AE89BF/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003114</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Gilles de la tourette's syndrome in twins: Clinical and neurochemical data</title><author><name sortKey="Goetz" sort="Goetz" uniqKey="Goetz" last="Goetz">Goetz</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Tanner, Caroline M" sort="Tanner, Caroline M" uniqKey="Tanner C" first="Caroline M." last="Tanner">Caroline M. Tanner</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1990">1990</date><biblScope unit="vol">5</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="173">173</biblScope><biblScope unit="page" to="175">175</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">EAF0236C1FEF2A15BE90024F65B51E6977AE89BF</idno><idno type="DOI">10.1002/mds.870050216</idno><idno type="ArticleID">MDS870050216</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine</term><term>Serotonin</term><term>Tics</term><term>Tourette's syndrome</term><term>Twins</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A pair of identical twins (probability of monozygosity by genetic marking = 99.99%) with Gilles de la Tourette's syndrome (GTS) were studied clinically and neurochemically. The two boys were distinguished within the family by dramatic differences in their behavior and tics. Twin 1 had severe motor tics, loud vocalizations, coprolalia, and school behavior problems, whereas twin 2 was only mildly affected. Neither boy had ever been treated with medication for his tic disorder. Lumbar puncture was performed on each after a night of bed rest. In spite of the marked clinical differences between the two boys, the major indices of dopamine and serotonin turnover in the cerebrospinal fluid were equivalent. Homovanillic acid levels were 65 and 60 ng/ml, respectively, and 5‐hydroxyindoleacetic acid levels were 36 and 39 ng/ml. Observation of these twins suggests that the phenotypic expression of GTS relates to more factors than inheritance. Neurochemical metabolites of dopamine and serotonin did not reflect the comparative clinical severity of GTS in these boys.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Dr. Goetz</name><affiliations><json:string>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</json:string></affiliations></json:item><json:item><name>Caroline M. Tanner</name><affiliations><json:string>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Tourette's syndrome</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Twins</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Tics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Dopamine</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Serotonin</value></json:item></subject><language><json:string>eng</json:string></language><abstract>A pair of identical twins (probability of monozygosity by genetic marking = 99.99%) with Gilles de la Tourette's syndrome (GTS) were studied clinically and neurochemically. The two boys were distinguished within the family by dramatic differences in their behavior and tics. Twin 1 had severe motor tics, loud vocalizations, coprolalia, and school behavior problems, whereas twin 2 was only mildly affected. Neither boy had ever been treated with medication for his tic disorder. Lumbar puncture was performed on each after a night of bed rest. In spite of the marked clinical differences between the two boys, the major indices of dopamine and serotonin turnover in the cerebrospinal fluid were equivalent. Homovanillic acid levels were 65 and 60 ng/ml, respectively, and 5‐hydroxyindoleacetic acid levels were 36 and 39 ng/ml. Observation of these twins suggests that the phenotypic expression of GTS relates to more factors than inheritance. Neurochemical metabolites of dopamine and serotonin did not reflect the comparative clinical severity of GTS in these boys.</abstract><qualityIndicators><score>3.789</score><pdfVersion>1.3</pdfVersion><pdfPageSize>576 x 828 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1068</abstractCharCount><pdfWordCount>1833</pdfWordCount><pdfCharCount>10889</pdfCharCount><pdfPageCount>3</pdfPageCount><abstractWordCount>163</abstractWordCount></qualityIndicators><title>Gilles de la tourette's syndrome in twins: Clinical and neurochemical data</title><genre><json:string>Serial article</json:string></genre><host><volume>5</volume><pages><total>3</total><last>175</last><first>173</first></pages><issn><json:string>0885-3185</json:string></issn><issue>2</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1990</publicationDate><copyrightDate>1990</copyrightDate><doi><json:string>10.1002/mds.870050216</json:string></doi><id>EAF0236C1FEF2A15BE90024F65B51E6977AE89BF</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/EAF0236C1FEF2A15BE90024F65B51E6977AE89BF/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/EAF0236C1FEF2A15BE90024F65B51E6977AE89BF/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/EAF0236C1FEF2A15BE90024F65B51E6977AE89BF/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Gilles de la tourette's syndrome in twins: Clinical and neurochemical data</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1990</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Gilles de la tourette's syndrome in twins: Clinical and neurochemical data</title><author><persName><surname>Goetz</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, 1725 West Harrison Street, Chicago, IL 60612, U.S.A.</p></note><affiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation></author><author><persName><forename type="first">Caroline M.</forename><surname>Tanner</surname></persName><affiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1990"></date><biblScope unit="vol">5</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="173">173</biblScope><biblScope unit="page" to="175">175</biblScope></imprint></monogr><idno type="istex">EAF0236C1FEF2A15BE90024F65B51E6977AE89BF</idno><idno type="DOI">10.1002/mds.870050216</idno><idno type="ArticleID">MDS870050216</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1990</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>A pair of identical twins (probability of monozygosity by genetic marking = 99.99%) with Gilles de la Tourette's syndrome (GTS) were studied clinically and neurochemically. The two boys were distinguished within the family by dramatic differences in their behavior and tics. Twin 1 had severe motor tics, loud vocalizations, coprolalia, and school behavior problems, whereas twin 2 was only mildly affected. Neither boy had ever been treated with medication for his tic disorder. Lumbar puncture was performed on each after a night of bed rest. In spite of the marked clinical differences between the two boys, the major indices of dopamine and serotonin turnover in the cerebrospinal fluid were equivalent. Homovanillic acid levels were 65 and 60 ng/ml, respectively, and 5‐hydroxyindoleacetic acid levels were 36 and 39 ng/ml. Observation of these twins suggests that the phenotypic expression of GTS relates to more factors than inheritance. Neurochemical metabolites of dopamine and serotonin did not reflect the comparative clinical severity of GTS in these boys.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Tourette's syndrome</term></item><item><term>Twins</term></item><item><term>Tics</term></item><item><term>Dopamine</term></item><item><term>Serotonin</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1990">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/EAF0236C1FEF2A15BE90024F65B51E6977AE89BF/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="20"><doi origin="wiley" registered="yes">10.1002/mds.v5:2</doi><numberingGroup><numbering type="journalVolume" number="5">5</numbering><numbering type="journalIssue">2</numbering></numberingGroup><coverDate startDate="1990">1990</coverDate></publicationMeta><publicationMeta level="unit" type="shortCommunication" position="16" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870050216</doi><idGroup><id type="unit" value="MDS870050216"></id></idGroup><countGroup><count type="pageTotal" number="3"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 1990 Movement Disorder Society</copyright><eventGroup><event type="firstOnline" date="2004-10-12"></event><event type="publishedOnlineFinalForm" date="2004-10-12"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">173</numbering><numbering type="pageLast">175</numbering></numberingGroup><correspondenceTo>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, 1725 West Harrison Street, Chicago, IL 60612, U.S.A.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870050216.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="1"></count><count type="referenceTotal" number="15"></count></countGroup><titleGroup><title type="main" xml:lang="en">Gilles de la tourette's syndrome in twins: Clinical and neurochemical data</title><title type="short" xml:lang="en">TOURETTE'S SYNDROME IN TWINS</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>Christopher G.</givenNames><familyName>Goetz</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Caroline M.</givenNames><familyName>Tanner</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Tourette's syndrome</keyword><keyword xml:id="kwd2">Twins</keyword><keyword xml:id="kwd3">Tics</keyword><keyword xml:id="kwd4">Dopamine</keyword><keyword xml:id="kwd5">Serotonin</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>A pair of identical twins (probability of monozygosity by genetic marking = 99.99%) with Gilles de la Tourette's syndrome (GTS) were studied clinically and neurochemically. The two boys were distinguished within the family by dramatic differences in their behavior and tics. Twin 1 had severe motor tics, loud vocalizations, coprolalia, and school behavior problems, whereas twin 2 was only mildly affected. Neither boy had ever been treated with medication for his tic disorder. Lumbar puncture was performed on each after a night of bed rest. In spite of the marked clinical differences between the two boys, the major indices of dopamine and serotonin turnover in the cerebrospinal fluid were equivalent. Homovanillic acid levels were 65 and 60 ng/ml, respectively, and 5‐hydroxyindoleacetic acid levels were 36 and 39 ng/ml. Observation of these twins suggests that the phenotypic expression of GTS relates to more factors than inheritance. Neurochemical metabolites of dopamine and serotonin did not reflect the comparative clinical severity of GTS in these boys.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Gilles de la tourette's syndrome in twins: Clinical and neurochemical data</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>TOURETTE'S SYNDROME IN TWINS</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Gilles de la tourette's syndrome in twins: Clinical and neurochemical data</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Goetz</namePart><affiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation><description>Correspondence: Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, 1725 West Harrison Street, Chicago, IL 60612, U.S.A.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Caroline M.</namePart><namePart type="family">Tanner</namePart><affiliation>Department of Neurological Sciences, Rush Presbyterian–St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">shortCommunication</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1990</dateIssued><copyrightDate encoding="w3cdtf">1990</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">1</extent><extent unit="references">15</extent></physicalDescription><abstract lang="en">A pair of identical twins (probability of monozygosity by genetic marking = 99.99%) with Gilles de la Tourette's syndrome (GTS) were studied clinically and neurochemically. The two boys were distinguished within the family by dramatic differences in their behavior and tics. Twin 1 had severe motor tics, loud vocalizations, coprolalia, and school behavior problems, whereas twin 2 was only mildly affected. Neither boy had ever been treated with medication for his tic disorder. Lumbar puncture was performed on each after a night of bed rest. In spite of the marked clinical differences between the two boys, the major indices of dopamine and serotonin turnover in the cerebrospinal fluid were equivalent. Homovanillic acid levels were 65 and 60 ng/ml, respectively, and 5‐hydroxyindoleacetic acid levels were 36 and 39 ng/ml. Observation of these twins suggests that the phenotypic expression of GTS relates to more factors than inheritance. Neurochemical metabolites of dopamine and serotonin did not reflect the comparative clinical severity of GTS in these boys.</abstract><subject lang="en"><genre>Keywords</genre><topic>Tourette's syndrome</topic><topic>Twins</topic><topic>Tics</topic><topic>Dopamine</topic><topic>Serotonin</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>173</start><end>175</end><total>3</total></extent></part></relatedItem><identifier type="istex">EAF0236C1FEF2A15BE90024F65B51E6977AE89BF</identifier><identifier type="DOI">10.1002/mds.870050216</identifier><identifier type="ArticleID">MDS870050216</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1990 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003114 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003114 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:EAF0236C1FEF2A15BE90024F65B51E6977AE89BF
|texte= Gilles de la tourette's syndrome in twins: Clinical and neurochemical data
}}
| This area was generated with Dilib version V0.6.23. |  |